查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
植入式医疗器械市场规模，按产品类型，按设备性质，按最终用途，行业分析报告，区域展望，增长潜力，竞争市场份额和预测，2023-2032
市场调查报告书
商品编码
1237820

植入式医疗器械市场规模，按产品类型，按设备性质，按最终用途，行业分析报告，区域展望，增长潜力，竞争市场份额和预测，2023-2032

Implantable Medical Devices Market Size, By Product, By Type, By Nature of Device, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 492 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球植入式医疗设备市场将在 2032 年之前实现积极增长，这是由于人们越来越倾向于使用生物材料以获得更好的生物相容性和治疗效果。预计。

此外，植入式医疗器械的一系列技术创新有望提升产品性能和临床疗效。

例如，相干公司将在 2023 年初推出全自动激光系统 AP 530 S，用于植入式医疗设备的标记和纹理□□化。 由于该过程是非接触式的，因此不存在污染风险，并且可以提高医疗器械的均匀性和质量水平。

知名公司正在开发高端植入技术和数据监控应用程序，以提供有关患者健康和设备性能的临床数据。 例如，强生公司在 2022 年 3 月透露，该公司的 DePuy Synthes 部门推出了两种最先进的膝关节植入物，即 ATTUNE 无水泥固定轴承膝关节和 ATTUNE 内侧稳定膝关节系统。 通过推出这一新产品，该公司扩大了产品组合併增加了收入份额。

植入式医疗器械市场根据产品、类型、器械性质、最终用途和地区进行细分。

从产品来看，从 2023 年到 2032 年，骨科领域预计将以超过 10.5% 的复合年增长率增长。 对身体属性的认识不断提高以及对某些美容标准的偏好不断增加，预计将推动市场扩张。

在最终用途方面，随着医院引入可提高治疗效果的尖端植入式设备，预计未来几年市场将显着增长。 此外，疾病筛查计划的增加、治疗心脏病和骨科疾病等慢性病的住院人数增加以及心脏病和骨科疾病住院人数的增加预计将对扩大医院部门。它是

按地区划分，从 2023 年到 2032 年，拉丁美洲的植入式医疗器械市场预计将以超过 10% 的复合年增长率增长。 该地区的扩张预计将受到该地区不断扩大的人口基数和医疗旅游增长的推动。 预计对用于治疗各种疾病的技术改进设备的需求也将推动拉丁美洲地区的市场扩张。

报告称，墨西哥是世界上第二大最受欢迎的医疗旅游目的地，有 140 至 300 万人涌入墨西哥寻求负担得起的治疗。

内容

第 1 章研究方法和范围

第 2 章执行摘要

第 3 章：植入式医疗器械行业洞察

  • 行业格局，2018-2032 年版
  • 影响行业的因素
    • 司机
      • 全球慢性病发病率增加
      • 缺乏器官捐献者
      • 发达国家的技术进步
      • 发达国家政府对植入式医疗设备的资助增加
      • 更加註重微电子和嵌入式传感器的开发
      • 采用生物材料来改善生物相容性和治疗效果
    • 行业潜在的风险和挑战
      • 设备成本高
      • 对有源植入式医疗器械的严格监管
      • 术后并发症的发生率显着提高
      • 大量植入式医疗器械召回
  • 增长分析
    • 按产品分类
    • 按类型
    • 由于设备的性质
    • 按最终用途
  • COVID-19 影响分析
  • 监管状况
    • 美国
    • 欧洲
    • 亚太地区
  • 退款场景
  • 技术概况
  • 2021 年价格分析
  • 植入式医疗器械製造材料的采用趋势
  • 波特分析
  • PESTEL 分析

第 4 章竞争格局，2021 年

  • 介绍
  • 竞争仪表板，2021 年
  • 2021 年公司矩阵分析
  • 2021 年公司股票分析

第 5 章植入式医疗器械市场：按产品分类

  • 主要细分趋势
  • 心血管系统
    • 起搏器
    • 植入式心律转復除颤器 (ICD)
    • 心臟再同步化治疗 (CRT)
    • 支架
    • 心室辅助装置
    • 植入式心臟监护仪 (ICM)
    • 其他
  • 骨科
    • 关节重建
    • 外伤固定装置
    • 脊柱装置
    • 其他
  • 眼科
    • 用于青光眼的人工晶状体/植入物
    • 其他
  • 整形外科
    • 乳房植入物
    • 髋关节植入物
  • 神经学
    • 深部脑刺激器
    • 其他
  • 牙科
    • 种植牙
    • 牙冠和基台
    • 其他
  • 其他

第 6 章植入式医疗器械市场：按类型

  • 主要细分趋势
  • 治疗
  • 诊断

第 7 章植入式医疗器械市场：按器械性质分类

  • 主要细分趋势
  • 活跃
  • 静态/非主动/被动

第 8 章植入式医疗器械市场：按最终用途分类

  • 主要细分趋势
  • 医院
  • 多专业中心
  • 门诊手术中心
  • 诊所
  • 其他

第 9 章植入式医疗器械市场：按地区

  • 主要区域趋势
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 波兰
    • 奥地利
    • 瑞士
    • 瑞典
    • 丹麦
    • 斯洛伐克
    • 捷克共和国
    • 芬兰
    • 比荷卢经济联盟
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
    • 台湾
    • 印度尼西亚
    • 泰国
    • 越南
    • 柬埔寨
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋

第十章公司简介

  • Medtronic Plc
  • Zimmer Biomet
  • AbbVie Inc.（Allergan plc）
  • MicroPort Scientific Corporation
  • Stryker Corporation
  • Smith & Nephew plc
  • Boston Scientific Corporation
  • Abbott Laboratories, Inc
  • Alcon Laboratories
  • Bausch & Lomb
  • Mindray Medical International Limited
  • POLYTECH Health & Aesthetics
  • MED-EL GmbH
  • Demant A/S
  • Advanced Bionics Corporation（Sonova Holdings AG）
  • Cochlear Limited
  • W. L. Gore & Associates, Inc
  • Johnson & Johnson
  • Henry Schein, Inc
  • BIOTRONIK SE & Co. KG
简介目录
Product Code: 4483

Global Implantable Medical Devices Market is expected to expand positively through 2032 owing to the surging preference for biomaterials to accomplish better biocompatibility as well as outcomes. Moreover, a slew of technological innovations in implantable medical devices is expected to boost product performance and clinical results.

To illustrate, Coherent Corporation in early 2023, launched a fully automated laser system, AP 530 S, for marking and texturing implantable medical devices. The process is contactless, which eliminates the risk of contamination and ensures improved level of uniformity and quality for medical devices.

Prominent companies are creating high-end implantable technologies as well as data monitoring applications that offer clinical data regarding patient health and device performance. For instance, in March 2022, Johnson & Johnson revealed that its DePuy Synthes division has introduced two cutting-edge knee implants, the ATTUNE Cementless Fixed Bearing Knee as well as the ATTUNE Medial Stabilized Knee System. The novel product launch helped the firm improve its product portfolio and boost its revenue share.

The implantable medical devices market has been divided in terms of product, type, nature of devices, end-use, and region.

Based on product, the plastic surgery segment is slated to grow at more than 10.5% CAGR from 2023 to 2032. Increased awareness of physical attributes as well as the burgeoning preference for a specific beauty standard is expected to drive market expansion.

With respect to end-use, the hospitals segment is anticipated to attain sizable market expansion over the review years fueled by the deployment of cutting-edge implantable devices in hospital settings that deliver improved outcomes. Other factors favorably influencing the expansion of the hospital segment include rising illness screening programs, growing hospitalizations for chronic disorder treatments, such as heart and orthopedic conditions, as well as rising admissions for heart and orthopedic problems.

From the regional perspective, the Latin America implantable medical devices market is speculated to grow at more than 10% CAGR from 2023 to 2032. The regional expansion is expected to be driven by expanding population base throughout the region and an increase in medical tourism. The demand for technologically improved equipment for the treatment of various diseases is also expected to drive market expansion in the LATAM region.

As per reports, Mexico stands as the second most popular destination for medical tourism worldwide, with an influx of 1.4 million to 3 million people to take advantage of inexpensive treatment.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 North America
    • 1.3.2 Europe
    • 1.3.3 Asia Pacific
    • 1.3.4 Latin America
    • 1.3.5 MEA
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 COVID-19 impact analysis at global level
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Implantable medical devices industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Type trends
    • 2.1.4 Nature of device trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Implantable Medical Devices Industry Insights

  • 3.1 Industry landscape, 2018 - 2032
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of chronic diseases across the globe
      • 3.2.1.2 Scarcity of organ donors
      • 3.2.1.3 Technological advancement in developed nations
      • 3.2.1.4 Rising government funding for implantable medical devices in developed countries
      • 3.2.1.5 Increasing focus on development of microelectronics and implantable sensors
      • 3.2.1.6 Growing adoption of biomaterials for better biocompatibility and outcomes
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of devices
      • 3.2.2.2 Stringent regulations for active implantable medical devices
      • 3.2.2.3 Considerable rate of post-procedural complications
      • 3.2.2.4 High number of recalls of implantable medical devices
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By type
    • 3.3.3 By nature of devices
    • 3.3.4 By end-use
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
    • 3.5.3 Asia Pacific
  • 3.6 Reimbursement scenario
  • 3.7 Technology landscape
  • 3.8 Pricing analysis, 2021
  • 3.9 Trend in adoption of materials for manufacture of implantable medical devices
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Competitive dashboard, 2021
  • 4.3 Company matrix analysis, 2021
  • 4.4 Company market share analysis, 2021

Chapter 5 Implantable Medical Devices Market, By Product

  • 5.1 Key segment trends
  • 5.2 Cardiovascular
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.2 Pacemaker
      • 5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.3 Implantable cardiac defibrillators (ICDs)
      • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.4 Cardiac Resynchronization Therapy (CRT)
      • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.5 Stents
      • 5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.6 Ventricular assist devices
      • 5.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.7 Implantable cardiac monitors (ICM)
      • 5.2.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.8 Others
      • 5.2.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Orthopedic
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Joint reconstruction
      • 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.3 Trauma fixation devices
      • 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.4 Spinal devices
      • 5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.5 Others
      • 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.4 Ophthalmology
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.4.2 Intraocular lenses & glaucoma implants
      • 5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.4.3 Others
      • 5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.5 Plastic surgery
    • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.5.2 Breast implants
      • 5.5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.5.3 Gluteal implants
      • 5.5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.6 Neurology
    • 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.6.2 Deep brain stimulators
      • 5.6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.6.3 Others
      • 5.6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.7 Dental
    • 5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.7.2 Dental implants
      • 5.7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.7.3 Dental crowns & abutment
      • 5.7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.7.4 Others
      • 5.7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.8 Others
    • 5.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Implantable Medical Devices Market, By Type

  • 6.1 Key segment trends
  • 6.2 Treatment
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Diagnostic
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Implantable Medical Devices Market, By Nature of Devices

  • 7.1 Key segment trends
  • 7.2 Active
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3 Static/Non-active/Passive
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Implantable Medical Devices Market, By End-use

  • 8.1 Key segment trends
  • 8.2 Hospitals
    • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.3 Multi-specialty centers
    • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.4 Ambulatory surgical centers
    • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.5 Clinics
    • 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.6 Others
    • 8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Implantable Medical Devices Market Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Poland
    • 9.3.7 Austria
    • 9.3.8 Switzerland
    • 9.3.9 Sweden
    • 9.3.10 Denmark
    • 9.3.11 Slovakia
    • 9.3.12 Czech Republic
    • 9.3.13 Finland
    • 9.3.14 Benelux
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Taiwan
    • 9.4.7 Indonesia
    • 9.4.8 Thailand
    • 9.4.9 Vietnam
    • 9.4.10 Cambodia
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Medtronic Plc
  • 10.2 Zimmer Biomet
  • 10.3 AbbVie Inc. (Allergan plc)
  • 10.4 MicroPort Scientific Corporation
  • 10.5 Stryker Corporation
  • 10.6 Smith & Nephew plc
  • 10.7 Boston Scientific Corporation
  • 10.8 Abbott Laboratories, Inc
  • 10.9 Alcon Laboratories
  • 10.10 Bausch & Lomb
  • 10.11 Mindray Medical International Limited
  • 10.12 POLYTECH Health & Aesthetics
  • 10.13 MED-EL GmbH
  • 10.14 Demant A/S
  • 10.15 Advanced Bionics Corporation (Sonova Holdings AG)
  • 10.16 Cochlear Limited
  • 10.17 W. L. Gore & Associates, Inc
  • 10.18 Johnson & Johnson
  • 10.19 Henry Schein, Inc
  • 10.20 BIOTRONIK SE & Co. KG